This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papagiannitsis, C. C.
Right arrow Articles by Miriagou, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papagiannitsis, C. C.
Right arrow Articles by Miriagou, V.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2009, p. 277-280, Vol. 53, No. 1
0066-4804/09/$08.00+0     doi:10.1128/AAC.00912-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Relative Strengths of the Class 1 Integron Promoter Hybrid 2 and the Combinations of Strong and Hybrid 1 with an Active P2 Promoter{triangledown}

Costas C. Papagiannitsis,1 Leonidas S. Tzouvelekis,2 and Vivi Miriagou1*

Laboratory of Bacteriology, Hellenic Pasteur Institute,1 Department of Microbiology, Medical School, University of Athens, Athens, Greece2

Received 10 July 2008/ Returned for modification 23 August 2008/ Accepted 2 November 2008

The relative strengths of the uncommon promoters hybrid 2, hybrid 1 with an active P2 promoter (hybrid 1+P2), and strong+P2, which drive transcription of resistance genes in class 1 integrons, were evaluated using blaGES-1 as a reporter gene cassette. Hybrid 2 was stronger than hybrid 1. Coupling P2 with the strong promoter and with hybrid 1 caused a measurable increase in GES-1 expression.


* Corresponding author. Mailing address: Laboratory of Bacteriology, Hellenic Pasteur Institute, Vas. Sofias 127, Athens 11521, Greece. Phone: 30-210-6478810. Fax: 30-210-6423626. E-mail: miriagou{at}pasteur.gr

{triangledown} Published ahead of print on 10 November 2008.


Antimicrobial Agents and Chemotherapy, January 2009, p. 277-280, Vol. 53, No. 1
0066-4804/09/$08.00+0     doi:10.1128/AAC.00912-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.